No actually I run down the inventory by the end of 2022 to maintain sales (which even so drop sharply in 2022). I would say the real difference between us is what production will be over the period. I have much lower production numbers and so inventory is run down over the next 18 months to pay dividends and provide cash for Atlas and growth projects.
As a warning depreciation is hard for an outsider to estimate and I suspect my number for 2022 may be too high. For example it depends in part on how much is spent on mine development at Atlas in 2022.
- Forums
- ASX - By Stock
- IMA
- Ann: Half Year Accounts
Ann: Half Year Accounts, page-44
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMA (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.4¢ |
Change
-0.001(0.68%) |
Mkt cap ! $83.10M |
Open | High | Low | Value | Volume |
7.4¢ | 7.4¢ | 7.4¢ | $15.79K | 213.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 156173 | 7.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.4¢ | 36003 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 156173 | 0.073 |
5 | 361822 | 0.072 |
1 | 55000 | 0.071 |
3 | 171220 | 0.070 |
1 | 10000 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.074 | 36003 | 3 |
0.075 | 20000 | 1 |
0.078 | 49297 | 1 |
0.079 | 55889 | 2 |
0.080 | 35495 | 1 |
Last trade - 15.56pm 15/07/2024 (20 minute delay) ? |
Featured News
IMA (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online